Citation Impact
Citing Papers
A tailored, dialogue-based health communication application for patients with chronic low back pain: study protocol of a randomised controlled trial
2013
Telemedicine for healthcare: Capabilities, features, barriers, and applications
2021 Standout
eMedOffice: A web-based collaborative serious game for teaching optimal design of a medical practice
2012
German Diabetes Management Programs Improve Quality Of Care And Curb Costs
2010
Immunocytochemical and Pharmacological Evidence for an Intrinsic Cholinomimetic System Modulating Prolactin and Growth Hormone Release in Rat Pituitary*
1988
Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects
1995
Mucus and MUC in asthma
2005
Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain
2016
Effect of Enhancement of Endogenous Cholinergic Tone with Pyridostigmine on the Dose-Response Relationships of Growth Hormone (GH)-Releasing Hormone-Induced GH Secretion in Normal Subjects*
1990
Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment
1992
Descending control of pain
2002 Standout
The association between compensation and chronic disabling back pain
2012
Cushing's syndrome
2015 Standout
Exercise Standards for Testing and Training
2013 Standout
Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants
2021 Standout
Effect of Galanin on the Growth Hormone (GH) Response to Ghreleasing Hormone in Patients with Cushing's Disease
1993
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Synthesis and Release of Acetylcholine by Normal and Tumoral Pituitary Corticotrophs*
1989
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Effectiveness of a Web-Based Tailored Interactive Health Communication Application for Patients With Type 2 Diabetes or Chronic Low Back Pain: Randomized Controlled Trial
2015
Beliefs and attitudes about opioid prescribing and chronic pain management: Survey of primary care providers
2014
ARGININE POTENTIATES THE GHRH‐ BUT NOT THE PYRIDOSTIGMINE‐INDUCED GH SECRETION IN NORMAL SHORT CHILDREN. FURTHER EVIDENCE FOR A SOMATOSTATIN SUPPRESSING EFFECT OF ARGININE
1990
Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats
1995
Anatomy and physiology of central galanin-containing pathways
1993
Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man
1993
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men
1995
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Status and perspectives of claims data analyses in Germany—A systematic review
2016 Standout
Effects of pyridostigmine on spontaneous and growth hormone‐releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation
1991
Poor Control Increases the Economic Cost of Asthma
2006
Evidence for Involvement of Endogenous Somatostatin in the Galanin-Induced Growth Hormone Secretion in Children
1990
Effect of the potentiation of cholinergic activity on the variability in individual GH response to GH-releasing hormone
1989
The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man
1991
Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release
1997
Patient Preference and Satisfaction with the Use of Telemedicine for Glycemic Control in Patients with Type 2 Diabetes: A Review
2021
PYRIDOSTIGMINE DOES NOT REVERSE DEXAMETHASONE‐INDUCED GROWTH HORMONE INHIBITION
1990
The late growth hormone rise induced by oral glucose is enhanced by cholinergic stimulation with pyridostigmine in normal subjects
1992
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Hypothalamic Mediation of Reduced GH Secretion in Diabetic Rats: Evidence for Reduced Cholinergic Inhibition of Somatostatin Release
1995
GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES
1988
EFFECTS OF CALCITONIN ON GH RESPONSE TO PYRIDOSTIGMINE IN COMBINATION WITH hGHRH (1–29) NH2 IN NORMAL ADULT SUBJECTS
1990
Impact of quality circles for improvement of asthma care: results of a randomized controlled trial
2007
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Structure and dynamics of the M3 muscarinic acetylcholine receptor
2012 StandoutNatureNobel
Pyridostigmine Blocks the Inhibitory Effect of Glucocorticoids on Growth Hormone-Releasing Hormone Stimulated Growth Hormone Secretion in Normal Man
1990
Ghrelin: Structure and Function
2005 Standout
EFFECT OF ENHANCEMENT OF ENDOGENOUS CHOLINERGIC TONE WITH PYRIDOSTIGMINE ON GROWTH HORMONE (GH) RESPONSES TO GH‐RELEASING HORMONE IN PATIENTS WITH CUSHING'S SYNDROME
1990
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Review on use of German health insurance medication claims data for epidemiological research
2009
Prevalence of Chronic Kidney Disease and Associated Risk Factors, and Risk of End-Stage Renal Disease: Data from the PREVADIAB Study
2011
Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine
1998
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Protective Role of 14-Deoxy-11,12-didehydroandrographolide, a Noncytotoxic Analogue of Andrographolide, in Allergic Airway Inflammation
2011 Standout
Testing with growth hormone-releasing factor (GRF(1–29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency
1986
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.
1992 Standout
An update to the systematic literature review of empirical evidence of the impacts and outcomes of computer games and serious games
2015 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Value of TENS for relief of chronic low back pain with or without radicular pain
2011
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
Prevalence of chronic low back pain: systematic review
2015 Standout
Neuronal M3muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth
2009
Neuroendocrine Control of Growth Hormone Secretion
1999
Works of Marcus Redaèlli being referenced
<p>TeDia - A Telemedicine-Based Treatment Model for Inpatient and Interprofessional Diabetes Care</p>
2019
Asthma: prevalence and cost of illness
2005
Implementation of a Guideline for Low Back Pain Management in Primary Care
2011
Disease management and health care reforms in Germany—Does more competition lead to less solidarity?
2006
Low Back Pain in Primary Care
2010
Diabetes—prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany
2005
Efficacy of a long-term secondary prevention programme following inpatient cardiovascular rehabilitation on risk and health-related quality of life in a low-education cohort: a randomized controlled study
2012
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin
1986
Population-Based Disease Management in the German Statutory Health Insurance
2006